title: Postexposure chemoprophylaxis for occupational exposure to HIV in the dental office.
abstract: Occupational exposure to HIV continues to be a concern for health care workers. Preventing exposure through the use of universal precautions is the primary means of protection. New Public Health Service interagency work group recommendations for postexposure chemoprophylaxis provide information to help manage occupational exposure to HIV.
authors.affiliation: Department of Internal Medicine, University of Michigan Health Systems, Ann Arbor, USA.
authors.forename: C E
authors.initials: CE
authors.lastname: Chenoweth
authors.forename: J P
authors.initials: JP
authors.lastname: Gobetti
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control / Q000635:transmission; D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D018890:Chemoprevention; D002648:Child; D003727:Dental Auxiliaries; D003815:Dentists; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control*; D019259:Lamivudine / Q000627:therapeutic use; D009784:Occupational Diseases / Q000517:prevention & control*; D016273:Occupational Exposure; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D014481:United States; D014492:United States Public Health Service; D016635:Universal Precautions; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir